Syon Capital’s SpringWorks Therapeutics SWTX Stock Holding History

Syon Capital’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-12,979	Closed	-$610K	–	846
2025 Q2	$610K	Sell	12,979 -273	-2%	-$12.1K	0.04%	314
2025 Q1	$585K	Sell	13,252 -304	-2%	-$14K	0.05%	280
2024 Q4	$490K	Buy	+13,556	New	+$474K	0.04%	289

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Syon Capital's SWTX Position: Q3 2025 in Review

Syon Capital sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 12,979 shares — an estimated $610K sold.

Syon Capital first reported a position in SWTX in Q4 2024 and held it in 3 quarters. The position peaked at $610K in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Syon Capital reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Syon Capital sold 12,979 SpringWorks Therapeutics shares in Q3 2025, an estimated $610K.
Syon Capital first reported a position in SpringWorks Therapeutics in Q4 2024 and held it in 3 quarters.
Syon Capital's SpringWorks Therapeutics position peaked at $610K in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Syon Capital's 13F filing for Q3 2025, filed 7 Nov 2025.